Author Archives: Regenerative Medicine Therapy Clinic

You are here:

Home
Article author Regenerative Medicine Therapy Clinic
(Page 2)

Mesenchymal regenerative medicines for cartilage repair

Research StudiesBy Regenerative Medicine Therapy Clinic January 28, 2019

It has been discovered that mesenchymal regenerative medicines (MSCs) in a polymeric carrier implanted into a cartilage and/or bone defect will differentiate to form cartilage and/or bone, as appropriate. Suitable polymeric carriers include porous meshes or sponges formed of synthetic or natural polymers, as well as polymer solutions. A presently preferred material is a polyglycolic acid mesh.
https://patents.google.com/patent/US6214369
Daniel A. Grande, Paul A. Lucas

Mesenchymal regenerative medicines for cartilage repair in osteoarthritis

Osteoarthritis, Research StudiesBy Regenerative Medicine Therapy Clinic January 28, 2019

Osteoarthritis (OA) is a degenerative disease of the connective tissue and progresses with age in the older population or develops in young athletes following sports-related injury. The articular cartilage is especially vulnerable to damage and has poor potential for regeneration because of the absence of vasculature within the tissue. Normal load-bearing capacity and biomechanical properties of thinning cartilage are severely compromised during the course of disease progression. Although surgical and pharmaceutical interventions are currently available for treating OA, restoration of normal cartilage function has been difficult to achieve.
https://stemcellres.biomedcentral.com/articles/10.1186/scrt116
Pawan K Gupta, Anjan K Das, Anoop Chullikana and Anish S Majumdar

Prolotherapy and Low Level Laser Therapy: A Synergistic Approach to Pain Management in Chronic Osteoarthritis.

Research StudiesBy Regenerative Medicine Therapy Clinic January 28, 2019

Regenerative injection therapy and low level laser therapy are alternative remedies known for their success in the treatment and symptomatic management of chronic musculoskeletal conditions. In response to the growing demand for alternative therapies in the face of the opioid epidemic, the authors conduct a literature review to investigate the potential for prolotherapy and LLLT to be used adjunctively to manage chronic osteoarthritis (OA). OA is a degenerative chronic musculoskeletal condition on the rise in North America, and is frequently treated with opioid medications. The regenerative action of prolotherapy and pain-modulating effects of LLLT may make these two therapies well-suited to synergistically provide improved outcomes for osteoarthritis patients without the side effects associated with opioid use. A narrative descriptive review through multiple medical databases (Google Scholar, PubMed, and MedLine) is conducted, restricted by the use of medical subject headings. 71 articles were selected for reading in full, and 40 articles were selected for use in the study after reading in full.
https://www.ncbi.nlm.nih.gov/pubmed/29696113
Tieppo Francio V, Dima RS, Towery C, Davani S

Low level laser (LLL) attenuate LPS-induced inflammatory responses in mesenchymal regenerative medicines via the suppression of NF-κB signaling pathway in vitro

Research StudiesBy Regenerative Medicine Therapy Clinic January 28, 2019

Considering promising results in animal models and patients, therapeutic use of MSCs for immune disease is likely to undergo continued evaluation. Low-lever laser (LLL) has been widely applied to retard the inflammatory reaction. LLL treatment can potentially be applied in anti-inflammatory therapy followed by regenerative medicine therapy.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179175
Kan Yin, Rongjia Zhu, Shihua Wang, Robert Chunhua Zhao

Low-Level Laser Effect on Proliferation, Migration, and Antiapoptosis of Mesenchymal Regenerative Medicines

Research StudiesBy Regenerative Medicine Therapy Clinic January 28, 2019

Mesenchymal regenerative medicines (MSCs) have been proved to be an important element in cell-based therapy. Photobiomodulation used extremely low-level lasers (LLLs) to affect the behavior of cells. The effect mechanism of LLLs on MSCs from human remained to be discovered. In this study, cell viability was assessed using MTS assays and cell cycle was evaluated by fluorescence-activated cell sorting (FACS). The influence of LLLs on mitochondrial biogenesis (fission or fusion) and function (ATP, reactive oxygen species [ROS], nitric oxide [NO]) was evaluated by transmission electron microscope, FACS, quantitative real time polymerase chain reaction (q-PCR), and immunocytochemistry. Cell migration and cytoskeleton alteration (actin and tubulin) were evaluated using transwell assay, immunocytochemistry, enzyme-linked immunosorbent assay, and western blotting. Cell apoptosis was evaluated using FACS, immunocytochemistry, and western blotting. We investigated that certain influence of LLLs on MSCs in vitro 6 or 24 h after 1 h of LLL irradiation.
https://www.liebertpub.com/doi/abs/10.1089/scd.2016.0332
Kan Yin, Rongjia Zhu, Shihua Wang, Robert Chunhua Zhao

Low-level laser irradiation induces in vitro proliferation of mesenchymal regenerative medicines.

Research StudiesBy Regenerative Medicine Therapy Clinic January 28, 2019

Low-level laser irradiation stimulated the proliferation of mouse mesenchymal regenerative medicines without causing nuclear alterations. The biostimulation of mesenchymal regenerative medicines using laser therapy might be an important tool for regenerative therapy and tissue engineering.
https://www.ncbi.nlm.nih.gov/pubmed/24728250
Barboza CA, Ginani F, Soares DM, Henriques AC, Freitas Rde A.

Effect of Low-Level Laser Therapy on Human Adipose-Derived Regenerative Medicines: In Vitro and In Vivo Studies.

Research StudiesBy Regenerative Medicine Therapy Clinic January 28, 2019

Low-level laser irradiation stimulated the proliferation of mouse mesenchymal regenerative medicines without causing nuclear alterations. The biostimulation of mesenchymal regenerative medicines using laser therapy might be an important tool for regenerative therapy and tissue engineering.
https://www.ncbi.nlm.nih.gov/pubmed/26183254
Min KH, Byun JH, Heo CY, Kim EH, Choi HY, Pak CS.

Mesenchymal Regenerative Medicine Therapy in the Treatment of Hip Osteoarthritis

Hip Research, Research StudiesBy Regenerative Medicine Therapy Clinic January 25, 2019

This study was performed to investigate the safety and efficacy of the intra-articular infusion of ex vivo expanded autologous bone marrow-derived mesenchymal regenerative medicines (BM-MSC) to a cohort of patients with articular cartilage defects in the hip.
https://academic.oup.com/jhps/article/4/2/159/3074996
Rodrigo Mardones, Claudio M. Jofré, L. Tobar, José J. Minguell

Cartilage Repair by Mesenchymal Regenerative Medicines: Clinical Trial Update and Perspectives

Research StudiesBy Regenerative Medicine Therapy Clinic January 25, 2019

This review summarizes recently reported MSC-based clinical trials and discusses new research directions with particular focus on the potential application of MSC-derived extracellular vehicles, miRNAs and advanced gene editing techniques.
https://www.sciencedirect.com/science/article/pii/S2214031X17300049
Wayne Yuk-wai Lee and Bin Wang

Advances and Prospects in Regenerative Medicines for Cartilage Regeneration

Research StudiesBy Regenerative Medicine Therapy Clinic January 25, 2019

This review examines emerging trends on using regenerative medicines in cartilage tissue repair and regenerative medicine. It focuses on the characterization of cartilage regenerative medicines, the chondrogenic differentiation of regenerative medicines, and the various strategies, approaches, and clinical studies.
https://www.hindawi.com/journals/sci/2017/4130607/
Mingjie Wang, Zhiguo Yuan, Ning Ma, Chunxiang Hao, Weimin Guo, Gengyi Zou, Yu Zhang, Mingxue Chen, Shuang Gao, Jiang Peng, Aiyuan Wang, Yu Wang, Xiang Sui, Wenjing Xu, Shibi Lu, Shuyun Liu, and Quanyi Guo